Dandan Zhang Selected Research

ganoderic acid A

7/2021	Ganoderic Acid A Attenuates LPS-Induced Neuroinflammation in BV2 Microglia by Activating Farnesoid X Receptor.
1/2021	Activation of FXR by ganoderic acid A promotes remyelination in multiple sclerosis via anti-inflammation and regeneration mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dandan Zhang Research Topics

Disease

61	Neoplasms (Cancer) 12/2021 - 01/2009
22	Inflammation (Inflammations) 03/2022 - 12/2012
13	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2014
13	Neoplasm Metastasis (Metastasis) 05/2020 - 05/2013
11	Infections 10/2022 - 12/2011
7	Type 2 Diabetes Mellitus (MODY) 07/2022 - 05/2008
7	Cognitive Dysfunction 01/2022 - 01/2018
6	COVID-19 06/2022 - 05/2020
6	Hypertension (High Blood Pressure) 01/2022 - 01/2019
6	Carcinogenesis 12/2021 - 02/2015
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2010
6	Myocardial Infarction 01/2020 - 05/2014
6	Lung Neoplasms (Lung Cancer) 10/2017 - 01/2014
5	Wounds and Injuries (Trauma) 10/2022 - 06/2011
5	Kashin-Beck Disease 03/2022 - 05/2019
5	Body Weight (Weight, Body) 01/2022 - 01/2019
5	Retinal Degeneration 01/2022 - 10/2017
5	Obesity 12/2021 - 01/2014
5	Pain (Aches) 10/2021 - 06/2007
5	Heart Failure 09/2021 - 02/2006
5	Stroke (Strokes) 01/2021 - 05/2014
4	Lymphoma (Lymphomas) 07/2022 - 08/2016
4	Schizophrenia (Dementia Praecox) 12/2021 - 01/2016
4	Atherosclerosis 12/2021 - 01/2017
4	Neuroinflammatory Diseases 11/2021 - 10/2019
4	Hepatocellular Carcinoma (Hepatoma) 05/2020 - 05/2013
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2020 - 09/2014
4	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2016
4	Hypoxia (Hypoxemia) 01/2020 - 01/2010
4	Carcinoma (Carcinomatosis) 01/2019 - 01/2009
3	Chronic Hepatitis B 07/2022 - 01/2015
3	Pneumonia (Pneumonitis) 05/2022 - 06/2018
3	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 01/2018
3	Diabetes Mellitus 01/2022 - 06/2011
3	Osteoarthritis 12/2021 - 01/2019
3	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 10/2019
3	Cataract (Cataracts) 01/2021 - 01/2018
3	Fibrosis (Cirrhosis) 01/2021 - 01/2018
3	Adenocarcinoma of Lung 01/2020 - 01/2009
3	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 12/2013
2	Goiter 08/2022 - 03/2022
2	Critical Illness (Critically Ill) 06/2022 - 10/2018
2	Dyspnea (Shortness of Breath) 05/2022 - 06/2018
2	Fatigue 02/2022 - 04/2021
2	Pre-Eclampsia (Preeclampsia) 02/2022 - 12/2010
2	Hepatitis B 02/2022 - 11/2015
2	Insulin Resistance 01/2022 - 12/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 09/2020
2	Non-alcoholic Fatty Liver Disease 01/2022 - 12/2021
2	Circulating Neoplastic Cells 01/2022 - 05/2013
2	Blindness (Hysterical Blindness) 01/2022 - 01/2022
2	Ulcer 01/2022 - 06/2011
2	Rupture 01/2022 - 07/2014
2	Squamous Cell Carcinoma of Head and Neck 12/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2010
15	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2016
11	Pharmaceutical PreparationsIBA 04/2021 - 01/2009
10	Long Noncoding RNAIBA 02/2022 - 02/2015
10	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 11/2012
9	Biological ProductsIBA 02/2022 - 01/2015
9	MicroRNAs (MicroRNA)IBA 02/2022 - 08/2015
9	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 12/2013
8	EnzymesIBA 04/2021 - 07/2014
6	CytokinesIBA 07/2022 - 01/2018
6	Messenger RNA (mRNA)IBA 06/2022 - 01/2010
6	Retinaldehyde (Retinal)IBA 01/2022 - 01/2018
5	LipidsIBA 12/2021 - 01/2013
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2009
5	Epithelial Cell Adhesion MoleculeIBA 01/2020 - 01/2017
4	Peptides (Polypeptides)IBA 01/2022 - 01/2016
4	Therapeutic UsesIBA 01/2022 - 01/2018
4	Metformin (Glucophage)FDA LinkGeneric 12/2021 - 02/2015
4	Antineoplastic Agents (Antineoplastics)IBA 04/2021 - 10/2017
4	AntigensIBA 01/2017 - 12/2011
3	CollagenIBA 10/2022 - 11/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 06/2018
3	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2009
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 11/2015
3	Neuroprotective AgentsIBA 01/2022 - 08/2018
3	Uric Acid (Urate)IBA 01/2021 - 04/2018
3	Blood Glucose (Blood Sugar)IBA 01/2021 - 06/2011
3	oxidized low density lipoproteinIBA 01/2021 - 01/2019
3	CuprizoneIBA 01/2021 - 10/2019
3	AntibodiesIBA 01/2021 - 01/2015
2	LipopolysaccharidesIBA 03/2022 - 01/2019
2	Phenobarbital (Luminal)FDA Link 03/2022 - 02/2015
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 02/2022 - 01/2018
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 01/2019
2	MethyltransferasesIBA 01/2022 - 03/2020
2	Streptozocin (Streptozotocin)FDA Link 01/2022 - 06/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 01/2021
2	human ERBB2 proteinIBA 01/2022 - 02/2015
2	Agammaglobulinaemia Tyrosine KinaseIBA 12/2021 - 11/2021

Therapy/Procedure

32	Therapeutics 06/2022 - 01/2013
10	Drug Therapy (Chemotherapy) 04/2021 - 05/2013
6	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2022 - 02/2017
4	Neoadjuvant Therapy 03/2022 - 04/2020
2	Continuous Renal Replacement Therapy 06/2022 - 10/2018
2	Transplantation 01/2022 - 01/2019
2	Immunotherapy 12/2021 - 10/2017